Study | Country | Year | MMPs type | Mode of detection | Polymorphism | Case/Control group | OR | 95%CI | p-value | Tumour |
---|---|---|---|---|---|---|---|---|---|---|
Chaudhary et al[57] | India | 2010 | MMP-3 | PCR-RFLP | -1171 5A/6A | 101/126 135/126 | 2.26 1.94 | 1.22-4.20 1.06-3.51 | 0.01 0.03 | HNSCC OSMF |
Shimizu et al[36] | Japan | 2008 | MMP-1 IL-8 | PCR-RFLP, IHC | -1607 1G/2G IL-8-251 A/A | - | - - | - - | 0.001 0.003 | TSCC |
Wu et al[61] | China | 2008 | MMP-9 | PCR-RFLP | P574R C>G | - | 4.1 | 1.58-10.52 | 0.00 | ESCC |
Tu et al[62] | Taiwan | 2007 | MMP-9 | PCR-RFLP | -1562 C>T | 192/191 73/191 | - | - | 0.029 | OSCC OSMF |
Nasr et al[38] | North Africa | 2007 | MMP-9 MMP-1 | PCR-RFLP | -1562 C/T -1607 1G/2G | 174/171 | - 2.9 | - | - 0.02 | - NPC |
Vairaktaris et al[63] | Greece | 2008 | MMP-9 | PCR-RFLP | -1562 C/T | 152/162 | 1.9 | 1.21-3.06 | 0.05 | OSCC |
Vairaktaris et al[55] | Greece | 2007 | MMP-3 MMP-1 | PCR-RFLP | -1171 5A/6A -1607 1G/2G | 160/156 141/156 | 2.2 - | 1.0-4.5 - | < 0.05 < 0.05 | OSCC |
Nishizawa et al[37] | Japan | 2007 | MMP-1 MMP-3 | PCR-RFLP | -1607 1G/2G -1171 5A/6A | 170/164 | 2.4 - | 1.5-4.6 - | 0.000 - | OSCC |
O-Charoenrat and Khantapura[51] | Thailand | 2006 | TIMP-2 MMP-2 | PCR-RFLP | -418GC or CC -1306C-->T | 239/250 239/250 | 1.43 1.97 | 0.98-2.08 1.23-3.15 | - - | HNSCC |
Tu et al[56] | Taiwan | 2006 | MMP-3 | PCR-RFLP | -1171 5A/6A | 150/98 71/98 | 1.7 2.62 | 0.84-3.445 1.20-5.71 | 0.18 0.01 | OSCC OSF |
Cao and Li[41] | China | 2006 | MMP-1 | PCR-RFLP | -1607 1G/2G | 96/120 | 2.2 | 1.5-3.4 | 0.000 | OSCC |
Zinzindohoue et al[42] | France | 2004 | MMP-1 MMP-3 | PCR-RFLP | -1607 1G/2G -1171 5A/6A | 126/249 | 0.37 - | 0.2-0.7 - | 0.003 - | HNSCC |
Lin et al[52] | Taiwan | 2004 | MMP-2 | PCR & dHPLC | -1306 C>T | 121/147 58/147 | 2.0 | - | - | OSCC OSF |
Hashimoto et al[44] | Japan | 2004 | MMP-1 MMP-3 | PCR-RFLP | -1607 1G/2G -1171 5A/6A | 140/223 | 1.6 NS | - - | 0.04 NS | HNSCC |